18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer
US-12054458-B2 · Aug 6, 2024 · US
This page is not indexed by search engines while we improve data quality.
Patent family 57121178
This patent family groups 5 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 57121178 |
| Family type | — |
| Earliest priority | Sep 30, 2015 |
| First filing country | US |
| Member publications | 5 |
| Countries | US |
| Representative publication | US12054458B2 — 18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer |
Representative publication
Best representative member for this family based on priority and filing country.
US12054458B2 — 18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer (published Aug 6, 2024)
Member publications
Related publications in this family.
18f - tagged inhibitors of prostate specific membrane antigen (psma) and their use as imaging agents for prostate cancer
US-2023295092-A1 · Sep 21, 2023 · US
18f - tagged inhibitors of prostate specific membrane antigen (psma) and their use as imaging agents for prostate cancer
US-2021053922-A1 · Feb 25, 2021 · US
18F—tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer
US-10815200-B2 · Oct 27, 2020 · US
18f - tagged inhibitors of prostate specific membrane antigen (psma) and their use as imaging agents for prostate cancer
US-2018194729-A1 · Jul 12, 2018 · US